Chargement en cours...
Management of Crohn’s disease in an immunosuppressed COVID-19-positive patient: safety-driven prioritisation of nutritional therapy as a bridge to restarting immunosuppression
Active inflammatory bowel disease (IBD), combined immunosuppression and corticosteroid therapy have all been identified as risk factors for a poor outcome in COVID-19 infection. The management of patients with both COVID-19 infection and active IBD is therefore complex. We present the case of a 31-y...
Enregistré dans:
| Publié dans: | BMJ Case Rep |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7986758/ https://ncbi.nlm.nih.gov/pubmed/33753379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-239404 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|